Clinical Trial Update: Effects of Berberine Hydrochloride and Bifidobacterium in Diabetes Mellitus Prevention and Treatment [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 study evaluating berberine hydrochloride and bifidobacterium for Type 2 diabetes mellitus was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Berberine hydrochloride (berberine hydrochloride)
• Bifidobacterium (Bifidobacterium)

Snippet

Sponsor: Xijing Hospital | Conditions: Type 2 Diabetes Mellitus | Phase 2, Phase 3 | Status: WITHDRAWN